268 related articles for article (PubMed ID: 32887976)
1. Transforming clinical trials in rheumatology: towards patient-centric precision medicine.
Pitzalis C; Choy EHS; Buch MH
Nat Rev Rheumatol; 2020 Oct; 16(10):590-599. PubMed ID: 32887976
[TBL] [Abstract][Full Text] [Related]
2. The approach to precision medicine for the treatment of psoriatic arthritis.
Miyagawa I; Tanaka Y
Immunol Med; 2020 Sep; 43(3):98-102. PubMed ID: 32306849
[TBL] [Abstract][Full Text] [Related]
3. Psoriatic arthritis therapy advances.
Mease PJ
Curr Opin Rheumatol; 2005 Jul; 17(4):426-32. PubMed ID: 15956839
[TBL] [Abstract][Full Text] [Related]
4. [Rheumatology (rheumatoid arthritis, psoriatic arthritis, Spondyloarthritis): What are the most important innovations in the last 10 years?].
Mayet WJ
MMW Fortschr Med; 2018 Nov; 160(Suppl 3):50-54. PubMed ID: 30421196
[No Abstract] [Full Text] [Related]
5. Tailored first-line biologic therapy in patients with rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis.
Cantini F; Niccoli L; Nannini C; Cassarà E; Kaloudi O; Giulio Favalli E; Becciolini A; Biggioggero M; Benucci M; Li Gobbi F; Grossi V; Infantino M; Meacci F; Manfredi M; Guiducci S; Bellando-Randone S; Matucci-Cerinic M; Foti R; Di Gangi M; Mosca M; Tani C; Palmieri F; Goletti D;
Semin Arthritis Rheum; 2016 Apr; 45(5):519-32. PubMed ID: 26607440
[TBL] [Abstract][Full Text] [Related]
6. The Changing Face of Clinical Trials in Psoriatic Arthritis.
Ogdie A; Coates L
Curr Rheumatol Rep; 2017 Apr; 19(4):21. PubMed ID: 28365920
[TBL] [Abstract][Full Text] [Related]
7. Persistence of biological agents over an eight-year period in rheumatoid arthritis and spondyloarthritis patients.
González-Fernández MÁ; Villamañán E; Jiménez-Nácher I; Moreno F; Herrero A; Balsa A
Farm Hosp; 2019 Jan; 43(1):24-30. PubMed ID: 30624170
[TBL] [Abstract][Full Text] [Related]
8. Gene therapy for arthritis--where do we stand?
Chernajovsky Y
Arthritis Res Ther; 2005; 7(6):227-9. PubMed ID: 16277696
[TBL] [Abstract][Full Text] [Related]
9. Management of rheumatoid arthritis: the 2012 perspective.
Yamanaka H; Seto Y; Tanaka E; Furuya T; Nakajima A; Ikari K; Taniguchi A; Momohara S
Mod Rheumatol; 2013 Jan; 23(1):1-7. PubMed ID: 22772460
[TBL] [Abstract][Full Text] [Related]
10. Treatment guidelines in psoriatic arthritis.
Ogdie A; Coates LC; Gladman DD
Rheumatology (Oxford); 2020 Mar; 59(Suppl 1):i37-i46. PubMed ID: 32159790
[TBL] [Abstract][Full Text] [Related]
11. Disease-modifying Antirheumatic Drugs (DMARD) and Combination Therapy of Conventional DMARD in Patients with Spondyloarthritis and Psoriatic Arthritis with Axial Involvement.
Simone D; Nowik M; Gremese E; Ferraccioli GF
J Rheumatol Suppl; 2015 Nov; 93():65-9. PubMed ID: 26523061
[TBL] [Abstract][Full Text] [Related]
12. Systemic levels of IL-23 are strongly associated with disease activity in rheumatoid arthritis but not spondyloarthritis.
Melis L; Vandooren B; Kruithof E; Jacques P; De Vos M; Mielants H; Verbruggen G; De Keyser F; Elewaut D
Ann Rheum Dis; 2010 Mar; 69(3):618-23. PubMed ID: 19196728
[TBL] [Abstract][Full Text] [Related]
13. Therapies for psoriatic enthesopathy. A systematic review.
Ritchlin CT
J Rheumatol; 2006 Jul; 33(7):1435-8. PubMed ID: 16724370
[TBL] [Abstract][Full Text] [Related]
14. Biologic Therapies for Autoimmune and Connective Tissue Diseases.
Wolfe RM; Ang DC
Immunol Allergy Clin North Am; 2017 May; 37(2):283-299. PubMed ID: 28366477
[TBL] [Abstract][Full Text] [Related]
15. Non-pharmacological interventions for preventing job loss in workers with inflammatory arthritis.
Hoving JL; Lacaille D; Urquhart DM; Hannu TJ; Sluiter JK; Frings-Dresen MH
Cochrane Database Syst Rev; 2014 Nov; (11):CD010208. PubMed ID: 25375291
[TBL] [Abstract][Full Text] [Related]
16. Adherence to biologic therapies and associated factors in rheumatoid arthritis, spondyloarthritis and psoriatic arthritis: a systematic literature review.
López-González R; León L; Loza E; Redondo M; Garcia de Yébenes MJ; Carmona L
Clin Exp Rheumatol; 2015; 33(4):559-69. PubMed ID: 25602291
[TBL] [Abstract][Full Text] [Related]
17. Combination therapy for pain management in inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis).
Ramiro S; Radner H; van der Heijde D; van Tubergen A; Buchbinder R; Aletaha D; Landewé RB
Cochrane Database Syst Rev; 2011 Oct; (10):CD008886. PubMed ID: 21975788
[TBL] [Abstract][Full Text] [Related]
18. Treatment advances in psoriatic arthritis.
Ruderman EM
Curr Rheumatol Rep; 2005 Aug; 7(4):313-8. PubMed ID: 16045835
[TBL] [Abstract][Full Text] [Related]
19. Efficacy outcomes in phase 2 and phase 3 randomized controlled trials in rheumatology.
Kerschbaumer A; Smolen JS; Herkner H; Stefanova T; Chwala E; Aletaha D
Nat Med; 2020 Jun; 26(6):974-980. PubMed ID: 32313250
[TBL] [Abstract][Full Text] [Related]
20. Is precision medicine possible in rheumatic diseases? Lessons from selective use of targeted therapies in patients with psoriatic arthritis.
Miyagawa I; Tanaka Y
Expert Rev Clin Immunol; 2020 Feb; 16(2):199-206. PubMed ID: 31905298
[No Abstract] [Full Text] [Related]
[Next] [New Search]
